Depression, anxiety, stress and resilience among undergraduate health sciences students of a rural tertiary healthcare centre in Maharashtra during the Covid-19 lockdown: A cross-sectional, online survey

BACKGROUND The Covid-19 pandemic caused a rapidly evolving and confused situation. Health sciences students (HSSs) are not immune to depression, anxiety and stress during such a pandemic. We aimed to assess the relation between depression, anxiety, stress and resilience among undergraduate HSSs during the Covid-19 lockdown. METHODS We conducted a cross-sectional, online survey at a rural tertiary healthcare centre in Maharashtra. Data were recorded from study participants on sociodemographic details using the 21-item Depression, Anxiety and Stress Scale (DASS-21) and the Brief Resilience Scale (BRS). Data were analysed using SPSS software version 15.0. RESULTS A total of 381 students participated in the online survey. The prevalence of depression, anxiety and stress were 7.6%, 6.3% and 1.0%, respectively. There was a positive correlation between all three sub-scales of DASS-21. On BRS, 5 (1.3%) participants had high resilience, 216 (56.7%) had normal resilience and 160 (42.0%) had low resilience. Those respondents who had high resilience had lower rates of depression, anxiety and stress on DASS-21 sub-scales. CONCLUSION A proportion of HSSs had anxiety, depression and stress during the Covid-19 outbreak and lockdown. Respondents with high resilience had less frequent depression, anxiety and stress. In the long run, strengthening resilience of HSSs may be useful.

The Pandemic of 21st Century - COVID-19

The global pandemic of novel coronavirus disease is mainly caused by the infection of Coronavirus ‘SARS-CoV-2’. It is infecting persons of all ethnicity, race and community. Corona viruses are enveloped RNA viruses which range from 60 to 140 nm in diameter with spike like projections on their top. Coronavirus is affecting 199 countries, territories and international transport systems. Covid-19 is a recent pandemic, which started in Wuhan, China, at the end of 2019 and now it is affecting the whole world. WHO declared this outbreak as a pandemic on March 11, 2020. COVID-19 infection is transmitted by inhalation or contact with infected droplets or aerosols of infected persons, and the incubation period ranges from 5 to 14 days. Viral aerosols remain active for 3 hours in the air, 24 hours on cardboards, and 2 to 3 days on stainless steel and plastic. Symptoms are usually fever, cough, breathlessness, sore throat, malaise and fatigue. In some people, it may progress to pneumonia, multiple organ dysfunction, and acute respiratory distress syndrome. People with heart diseases, lung diseases, cancer, old age, diabetics, Immunosuppressed, and pregnant women are at higher risk for COVID-19 infection. To date, there are now more than 2,732,701 cases of COVID 19 globally with more than 191,150 deaths. In India, total cases are 23,502 with 722 deaths. First case of coronavirus was seen on 29 January 2020. On 24 March 2020, the government of India under Prime Minister Shri Narendra Modi ordered a nationwide lockdown for 21 days, after a 14-hour voluntary public curfew on 22nd March. India is one of the most populous countries of the world. India has the second largest population in the world. Due to the lack of vaccines, ventilators, targeted therapies, mass gatherings, the Indian government started lockdown, the largest exercise in the world with the second largest population. To reduce public movement, section 144 was implemented in many states. A full lockdown will help the collapse of the whole national health system

Association between Glutathione-S-Transferase and Gastric Carcinoma: A Case Control Study

Gastric carcinoma is the fourth most common cancer type and the second leading cause of cancer deaths worldwide. Every year, around 1 million new cases and 0.7 million deaths are caused due to gastric carcinoma. Gastrointestinal tract is involved in absorption and metabolism of toxic or potentially carcinogenic compounds which may be present in the food we eat. In this context, digestive tract may be considered as a major site of cancer in humans. Glutathione-S-Transferase (GST) is an important metabolizing enzyme, present in the epithelial cells of human GIT. As nearly all reactive, ultimate carcinogenic forms of chemicals are electrophiles, GST is substantially important as a mechanism for carcinogen detoxification. The present study was conducted to evaluate the role of GST in gastric carcinoma and analyse the level of serum GST in patients suffering from gastric carcinoma. METHODSThis is a case control study, conducted among 50 cases of gastric carcinoma and 50 age sex matched controls. Patients included in this study were diagnosed with gastric carcinoma, after clinical and histological examination. Circulating levels of GST were assayed in the in the serum of control group and in patients with gastric carcinoma, using standardized method. RESULTSMean GST activity in serum was significantly higher (p < 0001) in gastric carcinoma patients (8.24 ± 1.94) as compared to control (5.47 ± 0.52). After chemotherapy (12.34 ± 1.05) the activity of GST was significantly higher (p < 0001) than before chemotherapy (10.23 ± 2.12). The generation of free radicals is as reflected by increased GST and GST-π activity in carcinoma cases. CONCLUSIONSSerum GSTs measurement in plasma may be a useful tumour marker in stomach cancer and serum GSTs activity might be helpful in predicting the response of chemotherapy in advanced stages of cancer. GST values are helpful in predicting the radiation response. Overexpression of GST in neoplasia may be causal, allowing replicative advantage, or casual, accompanying clonal expansion. The major limitation to its widespread use is the time needed for doing the assay and until this is overcome it will remain primarily a research tool.